Latest Financial Position News

Aurum Resources has reported significant high-grade gold intercepts from its ongoing drilling at the Tchaga deposit in Côte d'Ivoire, reinforcing its growth potential ahead of major resource updates scheduled for early 2026.

Andean Silver Limited reports significant high-grade silver-gold drilling results at its Cerro Bayo Project in Chile, extending mineralisation beyond existing resources near key processing infrastructure. These findings set the stage for a resource update in the first half of 2026.

Ryzon Materials has lodged a second supplementary prospectus extending its capital raising offer and clarifying key debt-for-equity transactions with Yantai, updating its financial outlook ahead of ASX reinstatement.

Kingfisher Mining has completed its strategic acquisition of a diverse NSW copper-gold-silver-lead-zinc portfolio and is mobilizing drilling at the Copper Blow project in Broken Hill.

CVC Limited has issued $75 million in redeemable, unsecured notes set to trade on the ASX from December 11, offering investors an attractive 8.2% interest rate starting March 2026.

Anax Metals has completed a $2.4 million strategic placement by issuing over 219 million shares to Gold Valley Pilbara, strengthening its capital base. The placement was executed under existing capacity and accompanied by a cleansing notice confirming regulatory compliance.

Volt Resources Limited has had its trading suspension lifted following the release of an announcement about a new equity funding transaction, signaling renewed market activity.

Almonty Industries has priced an upsized US$112.5 million share offering to accelerate development of key tungsten and molybdenum projects, reinforcing its position amid tightening global supply chains.

Astral Resources has successfully raised A$65 million through a strongly supported placement to advance its Mandilla Gold Project and accelerate exploration across its Western Australian gold assets.

Orthocell has achieved its first commercial sales of Remplir™ in Hong Kong, marking a pivotal step in its Asian growth strategy and expanding its footprint across key global markets.

Algorae Pharmaceuticals has secured a $384,466 cash refund from the Australian Taxation Office, reinforcing its financial position to advance AI-driven drug discovery programs.

Ramelius Resources has announced an on-market buy-back program targeting up to 73.9 million ordinary shares, signaling a strategic move to manage capital and potentially boost shareholder value.